Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · Real-Time Price · USD

0.6010

-0.0153 (-2.48%)

At close: Jun 2, 2026, 4:00 PM EDT

0.5932

-0.0078 (-1.30%)

Pre-market: Jun 3, 2026, 7:52 AM EDT

Lexaria Bioscience Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 28, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Cash & Equivalents	5.13	1.8	6.5	1.35	5.81	10.92
Short-Term Investments	0.14	0.14	0.05	0.12	0.35	0.83
Cash & Short-Term Investments	5.27	1.95	6.55	1.48	6.16	11.75
Cash Growth	-19.46%	-70.32%	344.09%	-76.05%	-47.58%	794.97%
Accounts Receivable	0.04	0.37	0.15	0.19	0.2	0.34
Inventory	-	-	-	-	0.04	0.03
Other Current Assets	-	-	1.19	0.55	0.58	0.32
Total Current Assets	5.77	3.47	7.9	2.15	6.98	12.44
Net Property, Plant & Equipment	0.33	0.33	0.39	1.35	0.37	0.46
Other Intangible Assets	0.32	0.31	0.52	0.46	0.49	0.36
Other Long-Term Assets	0.78	0.77	1.03	0.05	0.86	0.82
Total Assets	6.49	4.18	8.87	3.08	7.83	13.27
Accounts Payable	0.18	1.46	1.07	0.24	0.15	0.11
Short-Term Debt	-	-	-	-	-	0.01
Current Portion of Leases	0.03	0.03	0.03	0.03	0.04	0.04
Unearned Revenue	-	-	0	-	-	-
Total Current Liabilities	0.21	1.49	1.1	0.27	0.19	0.15
Long-Term Leases	0.06	0.08	0.11	0.14	0.01	0.05
Total Long-Term Liabilities	0.06	0.08	0.11	0.14	0.01	0.05
Total Liabilities	0.28	1.57	1.21	0.4	0.2	0.2
Common Stock	0.02	0.02	0.02	0.01	0.01	0.01
Additional Paid-in Capital	73.14	66.5	59.6	48.8	47.04	45.09
Accumulated Other Comprehensive Income	-0.06	-0.07	-0.02	-	-	-
Retained Earnings	-66.51	-63.46	-51.56	-45.76	-39.1	-31.83
Total Common Shareholders' Equity	6.6	2.99	8.04	3.04	7.95	13.27
Minority Interest	-0.39	-0.39	-0.38	-0.36	-0.32	-0.2
Shareholders' Equity	6.21	2.6	7.66	2.68	7.63	13.06
Total Liabilities & Equity	6.49	4.18	8.87	3.08	7.83	13.27
Total Debt	0.09	0.11	0.14	0.16	0.05	0.1
Net Cash (Debt)	5.18	1.84	6.42	1.31	6.11	11.65
Net Cash Growth	181.85%	-71.38%	389.13%	-78.53%	-47.57%	907.31%
Net Cash Per Share	0.25	0.10	0.52	0.20	1.04	2.65
Book Value	6.6	2.99	8.04	3.04	7.95	13.27
Book Value Per Share	0.32	0.17	0.65	0.46	1.35	3.02
Tangible Book Value	6.28	2.68	7.52	2.58	7.46	12.9
Tangible Book Value Per Share	0.30	0.15	0.61	0.39	1.27	2.94

SEC Filings: 10-K · 10-Q